Chronic liver diseases pose a substantial health burden worldwide, with approximately two
million deaths each year. Branched-chain amino acids (BCAAs)—valine, leucine, and …

Branched chain amino acids (BCAAs), including leucine (Leu), isoleucine (Ile), and valine
(Val), play critical roles in the regulation of energy homeostasis, nutrition metabolism, gut …

Dairy intake, as a source of branched‐chain amino acids (BCAA), has been linked to a lower
incidence of type‐2‐diabetes and increased circulating odd‐chain fatty acids (OCFA). To …

Oral supplementation with branched-chain amino acids (BCAA; leucine, isoleucine, and
valine) in patients with liver cirrhosis potentially suppresses the incidence of hepatocellular …

Advanced chronic liver disease (ACLD) represents a complex and multifactorial clinical
entity characterized by liver dysfunction and associated complications. In recent years, the …

Branched-chain amino acids (BCAAs) are essential amino acids that are not synthesized in
our body; thus, they need to be obtained from food. They have shown to provide many …

Nonalcoholic fatty liver disease (NAFLD) is a globally widespread disease of increasing
clinical significance. The pathological progression of the disease from simple steatosis to …

Non-alcoholic fatty liver disease (NAFLD) is a significant problem because its prevalence is
increasing worldwide. Recent animal studies have identified gut microbiota as a potentially …

Current evidence supports the potential use of BCAAs as biomarkers of disease. However,
questions regarding the mechanisms underlying the relationship of BCAAs to disease …

The branched‐chain amino acids (BCAAs), namely, valine, leucine, and isoleucine, are
indispensable amino acids required for body protein synthesis. Unlike other amino acids …